Quick Answer
Lexaria Bioscience Corp. reported Operating Income of -$11.88 million for fiscal year 2025.
Lexaria Bioscience Corp. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$11.88M | -106.5% |
| 2024 | -$5.75M | +12.0% |
| 2023 | -$6.53M | +1.3% |
| 2022 | -$6.62M | -16.4% |
| 2021 | -$5.69M | -345.2% |
| 2016 | -$1.28M | +35.6% |
| 2015 | -$1.98M | -27.2% |
| 2014 | -$1.56M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| November 30, 2025 | -$1.57M | +41.5% | +58.0% |
| May 31, 2025 | -$3.75M | -115.2% | -36.3% |
| February 28, 2025 | -$2.75M | -311.8% | -2.2% |
| November 30, 2024 | -$2.69M | -136.2% | -54.4% |
| May 31, 2024 | -$1.74M | +27.4% | -160.9% |
| February 29, 2024 | -$668.0K | +49.5% | +41.4% |
| November 30, 2023 | -$1.14M | +32.8% | +52.6% |
| May 31, 2023 | -$2.40M | +0.7% | -81.4% |
- Lexaria Bioscience Corp. showed a decrease of -106.5% in Operating Income compared to the prior fiscal year.
- Over the 2014–2025 period, Lexaria Bioscience Corp.’s operating income has declined by 661.9% (from -$1.56 million to -$11.88 million).
- The most recent figure is from Lexaria Bioscience Corp.’s fiscal year 2025 report (Form 10-K), filed with the SEC on November 28, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: